Cargando…
Causal Bayesian machine learning to assess treatment effect heterogeneity by dexamethasone dose for patients with COVID-19 and severe hypoxemia
The currently recommended dose of dexamethasone for patients with severe or critical COVID-19 is 6 mg per day (mg/d) regardless of patient features and variation. However, patients with severe or critical COVID-19 are heterogenous in many ways (e.g., age, weight, comorbidities, disease severity, and...
Autores principales: | Blette, Bryan S., Granholm, Anders, Li, Fan, Shankar-Hari, Manu, Lange, Theis, Munch, Marie Warrer, Møller, Morten Hylander, Perner, Anders, Harhay, Michael O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120498/ https://www.ncbi.nlm.nih.gov/pubmed/37085591 http://dx.doi.org/10.1038/s41598-023-33425-3 |
Ejemplares similares
-
Use of days alive without life support and similar count outcomes in randomised clinical trials – an overview and comparison of methodological choices and analysis methods
por: Granholm, Anders, et al.
Publicado: (2023) -
Conservative vs. liberal fluid therapy in septic shock – Protocol for secondary Bayesian analyses of the CLASSIC trial
por: Sivapalan, Praleene, et al.
Publicado: (2022) -
Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID‐19 and severe hypoxaemia—Post hoc exploratory analyses of the COVID STEROID 2 trial
por: Granholm, Anders, et al.
Publicado: (2022) -
Untargeted antifungal therapy in adult patients with complicated intra-abdominal infection: protocol for a systematic review with meta-analysis
por: Petersen, Marie Warrer, et al.
Publicado: (2017) -
Lower versus higher oxygenation targets in critically ill patients with severe hypoxaemia: secondary Bayesian analysis to explore heterogeneous treatment effects in the Handling Oxygenation Targets in the Intensive Care Unit (HOT-ICU) trial
por: Klitgaard, Thomas L., et al.
Publicado: (2022)